Wells Fargo Is 'Fairly Valued,' Its Conservative Approach 'Feels Safer:' Analysts
Revenue fell 3% year over year to
For fiscal year 2025,
Also Read: Wells Fargo Braces For Economic Slowdown In 2025, CEO Expects ‘Volatility And Uncertainty'
- Truist Securities maintains the Buy rating on
Wells Fargo ( WFC ) with a price forecast of$84 . - Oppenheimer maintains a Perform rating for
Wells Fargo ( WFC ). - Piper maintains the overweight rating with a price forecast cut from
$77 to$75 .
The original forecast expected 1–2 rate cuts in 2025, while markets now expect about 3, analyst McDonald adds. It also assumed slightly higher 10-year yields than current levels. However, the CFO said a third Fed rate cut later in the year wouldn't significantly affect the company's 2025 net interest income forecast.
Oppenheimer analyst writes, "We think WFC and all the major banks will generally acquit themselves well in whatever the economic environment throws at them. We think WFC has high potential, but is relatively fairly valued for now, and we prefer BAC, C and USB at the point."
Analyst
Piper Sandler analyst says credit costs are a potential wild card for
That's due to a higher forecast for loan charge-offs (50 basis points vs. 44 in Q1) and some extra cushion for loan growth. Analyst
Piper maintains the overweight rating with a price target cut from
Price Action: WFC stock is up 0.88% at
Read Next:
- Omeros' New Leukemia Drug Team Ignites Hope For Cancer Fight
Photo by Bumble Dee via Shutterstock

Related News
-
Benzinga - 10 minutes ago
-
This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday
Benzinga - 11 minutes ago
-
Research Alert: CFRA Maintains Strong Buy Opinion On Shares Of Newmont Corporation
MT Newswires - 12 minutes ago
-
Top 2 Health Care Stocks That May Crash This Month
Benzinga - 9:00 AM ET 4/25/2025
-
Benzinga - 8:59 AM ET 4/25/2025
-
This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
Benzinga - 8:27 AM ET 4/25/2025
-
This United Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Friday
Benzinga - 8:26 AM ET 4/25/2025